Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been clinically diagnosed with Subjective Cognitive Decline (SCD) based on the SCD-I criteria
- People who score above 24 on a standard memory and thinking test (called the MMSE), taking into account their age and education level
- People who are able to carry out everyday tasks and activities independently, as measured by two standard assessment scales (ADL and IADL)
Who may not be able to join:
- People who have a history of head injury or brain trauma
- People who currently have a neurological condition (affecting the brain or nervous system) or a significant ongoing physical health condition
- People who are experiencing symptoms of psychosis, major depression, or a substance use disorder
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Salvatore Mazzeo, MD, PhD, Università Vita-Salute San Raffaele, Milano - Neurology Unit, IRCCS Policlinico San Donato, San Donato Milanese
Phone: +390252774236
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Diagnostic accuracy of biomarkers in detecting Alzheimer's disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.